EN
登录

盐野义收购日本烟草的制药业务

Shionogi Acquires Japan Tobacco's Pharma Operations

medthority 等信源发布 2025-05-09 11:00

可切换为仅中文


Shionogi is to pay around Yen 151bn ($1.05bn) for Japan Tobacco’s pharmaceutical operations, including listed subsidiary Torii Pharmaceutical, in what the mid-sized firm characterized as seeking access to the hospital sales sector in Japan. Shionogi will launch a 30-business day tender offer for shares in Tokyo Stock Exchange-listed Torii on 8 May 2025 at Yen 6,350 each, marking a premium of 21.4% over Torii’s 2 May closing price. .

盐野义制药公司将斥资约1510亿日元(10.5亿美元)收购日本烟草公司旗下的制药业务,包括上市子公司鸟居制药。这家中型制药公司将此举描述为寻求进入日本医院销售领域。盐野义将于2025年5月8日以每股6350日元的价格对在东京证券交易所上市的鸟居制药发起为期30个工作日的要约收购,这一价格较鸟居制药5月2日的收盘价溢价21.4%。

Type:

类型:

industry

行业